Cited by 66COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchInflammation biomarkers and pathways

Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection

Open access
Kesmez Can, Fatma, Özkurt, Zülal, Öztürk, Nurinnisa, Sezen, Selma·2021·International Journal of Clinical Practice

Abstract

BACKGROUND: COVID 19 was first observed in December 2019 and has affected the world entire. Effective laboratory markers and prognostic indicators are needed to predict the clinical progression of the disease. AIMS: The purpose of this study was to investigate IL6, IL8/CXCL8, and IP10/CXCL10, and biochemical parameters associated with SARS, MERS, and SARS-CoV-2 infections and their significance on prognosis in healthy volunteers and mild-moderate and severe COVID 19 patients. METHODS: Healthy volunteers (n = 30), and patients with mild-moderate (n = 30) and severe (n = 30) COVID-19 patients were included in the study. IL-6, IL-8, and IP-10 levels and biochemical parameters were assessed among the groups and their correlations with each other were subjected to statistical analysis. RESULTS: Blood serum IL-6, IL-8, and IP-10 levels were the highest in the severe patient group (P = .001), and also higher in the mild-moderate group as compared with the healthy volunteers (P = .001). Statistically significant positive correlations were identified between serum IL-8 and IL-6 levels (P = .001, r = 0.660), between serum IP-10 and IL-6 (P = .001, r = 0.599) and between serum IP-10 and IL-8 (P = .001, r = 0.729). CONCLUSIONS: A statistically significant difference was found in WBC, NE%, NE, LY%, LY, HB, BUN, total protein, albumin, d-dimer, sedimentation differed significantly between the groups. Biomarkers of potential significance in terms of the severity of COVID 19 disease were examined, and high IL-6, IL-8, IP-10, CRP, PCT, and LY parameters values emerged as associated with the severity of the disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ijcp.14970

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated levels of IL-6 and IL-8 may indicate infection as the causative agent of AIN.

    “In a similar context, elevated levels of IL-6 and IL-8 may indicate infection as the causative agent of AIN [59, 98–101].”

    From The diagnosis of acute interstitial nephritis caused by infection versus antibiotic-induced interstitial nephritis: a narrative review (2024) · cites this paper as [99]

    The Results (page unavailable) report higher serum IL-6 and IL-8 in patients with COVID-19 than in healthy volunteers. The paper does not examine AIN or establish that elevated levels indicate infection as its causative agent. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kesmez Can, F., Özkurt, Z., Öztürk, N., & Sezen, S.
Affiliations
  • Department of Infectious Diseases and Clinical Microbiology Atatürk University School of Medicine Erzurum Turkey
  • Atatürk University (TR)
Venue
International Journal of Clinical Practice
Publisher
Wiley
Published
2021-10-22
Volume
75
Issue
12
Pages
e14970-e14970
ISSN
  • 1368-5031 (ISSN-L)
  • 1742-1241
OpenAlex
W3205294997
Cited by
66
References
30
Citations by year
2026: 5 · 2025: 8 · 2024: 19 · 2023: 19 · 2022: 14 · 2021: 1
FWCI
4.19
Type
journal article
Language
en
Open access
Locations
  • International Journal of Clinical Practice (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
Atatürk Üniversitesi (THD‐2020‐8619)
Topics
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
Keywords
COVID-19 pandemic, SARS-CoV-2, interleukin-6, interleukin-8, CXCL10, disease severity, prognostic factors, C-reactive protein, procalcitonin, lymphocyte percentage, D-dimer, serum cytokines
MeSH terms
COVID-19, SARS-CoV-2, Humans, Prognosis, Severity of Illness Index, Biomarkers, Interleukin-6, Interleukin-8, Chemokine CXCL10

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review